Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 64, Issue 12, Pages 8423-8436Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.1c00401
Keywords
-
Categories
Funding
- European Union [675179, 754462]
- European Union through Netherlands Organization for Scientific Research (NWO) [016.150.366, 024.001.035]
Ask authors/readers for more resources
This study describes the systematic bottom-up development of a reversible covalent PPI stabilizer and investigates how its chemical properties affect the structural changes in the ternary 14-3-3/p65/molecular glue complex, ultimately leading to increased stability and high cooperativity.
Protein-protein modulation has emerged as a proven approach to drug discovery. While significant progress has been gained in developing protein- protein interaction (PPI) inhibitors, the orthogonal approach of PPI stabilization lacks established methodologies for drug design. Here, we report the systematic bottom-up development of a reversible covalent PPI stabilizer. An imine bond was employed to anchor the stabilizer at the interface of the 14-3-3/p65 complex, leading to a molecular glue that elicited an 81-fold increase in complex stabilization. Utilizing protein crystallography and biophysical assays, we deconvoluted how chemical properties of a stabilizer translate to structural changes in the ternary 14-3-3/p65/molecular glue complex. Furthermore, we explore how this leads to high cooperativity and increased stability of the complex.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available